Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Osteopatisk manipulativ behandling og postural kontrol: systemteknisk tilgang

20. oktober 2026 opdateret af: Jacek Cholewicki, Michigan State University

The overall goal of this project is to develop sensitive and objective clinical research tools for the assessment of postural control of the trunk. In order to accomplish this goal, we aim to quantify balance performance in an unstable seated task. Specifically, the investigators will quantify balance performance in low back pain participants before and after osteopathic manipulative treatment. The investigators hypothesize that there will be a significant improvement in balance performance after a single session of osteopathic manipulative treatment as well as after 4 sessions of osteopathic manipulative treatment and this improvement will be greater than any learning effect.

A secondary objective of this study is to quantify differences in patient-oriented outcome measures (e.g., self-reported pain, disability) in low back pain participants before and after osteopathic manipulative treatment. The investigators hypothesize that there will be a significant improvement in these self-reported outcomes following osteopathic manipulative treatment. The association between improvement in postural control parameters and patient-oriented measures will also be explored.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

95

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Michigan
      • East Lansing, Michigan, Forenede Stater, 48823
        • MSU Osteopathic Manipulative Medicine
      • Lansing, Michigan, Forenede Stater, 48891
        • MSU Musculoskeletal Rehabilitation
      • Lansing, Michigan, Forenede Stater, 48910
        • Michigan State University Center for Orthopedic Research

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

21 år til 65 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

All participants must meet all of the inclusion criteria to participate in the study. Below is a list of inclusion criteria for LBP participants:

  • Age 21-65 years
  • Independently ambulatory
  • Able to speak and read English
  • Able to understand study procedures and to comply with them for the entire length of the study.
  • Willing to be randomized to either immediate or delayed treatment group.
  • Musculoskeletal pain - primarily in the low back region
  • Pain rating equal to or greater than 3 out of10 as indicated on the Numeric Rating Scale for Pain
  • Disability equal to or greater than 26% as indicated on the Oswestry Disability Questionnaire

Exclusion Criteria:

All candidates meeting any of the exclusion criteria at baseline will be excluded from study participation. Exclusion criteria will be self-reported. However, during each treatment session, the physicians will be watching for clinical signs and symptoms not consistent with physical findings that are suggestive of the presence of any of the exclusion criteria. In such a case, further treatment will be discontinued and the subject will be excluded.

Below is a list of exclusion criteria:

  • Inability or unwillingness of individual to give written informed consent.
  • Physical therapy or any other form of manual medicine (e.g., Osteopathic Manipulative Medicine, Chiropractic Manipulation, etc.), acupuncture or spinal injections within one month prior to study enrollment
  • Workers' compensation benefits in the past 3 months or ongoing medical legal issues
  • Possibly pregnant
  • Obesity (BMI>32)
  • Currently using electrical implants (e.g., cardiac pacemakers, drug delivery pumps, etc.)

History of:

  • Spinal surgery
  • Spinal fracture
  • Spinal infection (e.g., osteomyelitis)
  • Cancer

Unresolved symptoms from:

  • Head trauma
  • Inner ear infection with associated balance and coordination problems
  • Orthostatic hypotension
  • Uncontrolled hypertension
  • Vestibular disorder (e.g. vertigo)

Current diagnosis of:

  • Significant spinal deformity (e.g., scoliosis > 20 degrees, torticollis)
  • Ankylosing spondylitis
  • Spondylolisthesis grades III or IV
  • Cauda equine syndrome
  • Rheumatoid arthritis
  • Osteoporosis
  • Angina or congestive heart failure symptoms
  • Active bleeding or infection in the back
  • Blindness
  • Seizures
  • Neurologic disease (e.g., Parkinson's disease, multiple sclerosis, cerebral palsy, Alzheimer's disease, amyotrophic lateral sclerosis, stroke or transient ischemic attack in the past year, cervical dystonia)

Conditions recognized by a physician any time during the study:

  • Significant or worsening signs of neurologic deficit
  • Symptoms are not consistent with mechanical findings
  • Other conditions impeding protocol implementation

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Grundvidenskab
  • Tildeling: Randomiseret
  • Interventionel model: Crossover opgave
  • Maskning: Tredobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: OMT first, then No intervention

This arm received osteopathic manipulative treatment (OMT) for approximately 4 weeks (once per week), then received no intervention after for approximately 4 weeks.

Up to 4 sessions of osteopathic manipulative treatment (once per week)

No interventions for approximately 4 weeks

Eksperimentel: No intervention, then OMT

This arm received no intervention after for approximately 4 weeks, then received osteopathic manipulative treatment (OMT) for approximately 4 weeks (once per week).

Up to 4 sessions of osteopathic manipulative treatment (once per week)

No interventions for approximately 4 weeks

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Postural Control
Tidsramme: Baseline, Week 1, Week 4 (crossover), & Week 8

Postural control will be assessed in an unstable seated task, in which subjects will be asked to balance on a specially designed seat that wobbles side to side. Participant will be asked to maintain their upright posture while keeping their eyes open. The root mean square error (difference between the trunk angle from their upright position) is computed then converted to Z-score based the study populations' baseline mean and standard deviation. The score ranged from -1.67 to 2.95. Z-score of 0 indicates study population's average at the baseline. Higher Z-score indicates worse performance.

Baseline, Week 1, Week 4 (crossover), & Week 8
Trunk Muscle Reflex Latency
Tidsramme: Baseline, Week 1, Week 4 (crossover), & Week 8

Subjects will be pulling with their trunk on a cable held by an electromagnet. The electromagnet will be suddenly released. Trunk muscle response to sudden load release will be measured on electromyographical recordings.

Baseline, Week 1, Week 4 (crossover), & Week 8

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Patient Reported Outcomes Measurement Information System (PROMIS)
Tidsramme: Baseline and Week 4 (crossover point)

Assesses changes in physical function, anxiety, depression, fatigue, sleep, satisfaction with social role, and pain with Patient Reported Outcomes Measurement Information System (PROMIS) 29 questionnaire. Patients rated the statements in each domain from 0-5. Scores are summed for each domain (ranges from 4 to 20), and converted to T-scores using PROMIS conversion table (for details see http://www.healthmeasures.net/promis-scoring-manuals) . T-score of 50 indicates population average with a standard deviation of 10. Higher scores indicate worse outcomes for pain interference, sleep disturbance, fatigue, depression, and anxiety; whereas higher scores indicate better outcomes for physical function and Satisfaction with participation in social roles.

Baseline and Week 4 (crossover point)
Concomitant Medication
Tidsramme: Baseline, Week 4 (crossover), Week8

Assesses the use of medication with a questionnaire. Patients were asked to report medications used within the past 7 days.

Baseline, Week 4 (crossover), Week8
Oswestry Disability Index
Tidsramme: Baseline, Week 4 (crossover), and Week 8

Assesses changes in functional activities related to low back disability with the Oswestry Disability Index questionnaire. Patients selected statements that best described their condition from 10 domains affecting daily life. Each domain is scored from 0 (no disability) to 5 (highest disability). Scores from each domains are summed then percentages are calculated out of 50. Higher percentage is associated with higher disability.

Baseline, Week 4 (crossover), and Week 8
Fear Avoidance Beliefs Questionnaire
Tidsramme: Baseline, Week 4 (crossover), and Week 8

The Fear Avoidance Beliefs questionnaire (FABQ) assesses effects of fear-avoidance beliefs about physical activity and work. Patients rated statements on a scale from 0 (completely disagree) to 6 (completely agree). Scores are then summed for each category: "Physical activity" (total of 4 statements, ranges from 0 to 24), and "Work" (total of 7 statements ranges from 0 to 42). Higher scores indicate stronger fear-avoidance belief (i.e. worse outcome).

Baseline, Week 4 (crossover), and Week 8

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Samarbejdspartnere

Efterforskere

  • Ledende efterforsker: Jacek Cholewicki, PhD, Michigan State University
  • Ledende efterforsker: Norman P Reeves, PhD, Michigan State University

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

5. juni 2015

Primær færdiggørelse (Faktiske)

31. august 2018

Studieafslutning (Faktiske)

31. august 2018

Datoer for studieregistrering

Først indsendt

19. september 2014

Først indsendt, der opfyldte QC-kriterier

9. oktober 2014

Først opslået (Anslået)

10. oktober 2014

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

12. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

20. oktober 2026

Sidst verificeret

1. oktober 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • NCCAM U19 AT006057 Project 1
  • 5U19AT006057-02 (U.S. NIH-bevilling/kontrakt)

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .